mRNA Synthesis and Manufacturing Services Market Size, Share and Growth Analysis 2025 to 2034

Report Id: 1185 Pages: 270 Last Updated: 17 December 2025 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Segmentation of mRNA Synthesis and Manufacturing Services Market-

mRNA Synthesis and Manufacturing Services Market By Products-

  • API
  • Drug Products

mrna synthesis

mRNA Synthesis and Manufacturing Services Market By Type of Industry-

  • Therapeutics and Vaccine Developers
  • CDMO Organizations
  • Custom Synthesis/Other Service Providers 

mRNA Synthesis and Manufacturing Services Market By Therapeutic Area-

  • Infectious Diseases
  • Oncological Disorders
  • Other Diseases

mRNA Synthesis and Manufacturing Services Market By Scale of Operation-

  • Research / Preclinical
  • Clinical
  • Commercial

mRNA Synthesis and Manufacturing Services Market By Application-

  • mRNA-based Vaccines
  • mRNA-based Therapeutics

mRNA Synthesis and Manufacturing Services Market By Region-

North America-

  • The US
  • Canada

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global mRNA Synthesis and Manufacturing Services Market Snapshot

Chapter 4. Global mRNA Synthesis and Manufacturing Services Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

4.9. Clinical Trial/Pipeline Analysis

Chapter 5. Market Segmentation 1: By Product Estimates & Trend Analysis

5.1. By Type of Industry & Market Share, 2024 & 2034

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Type of Industry:

5.2.1. API

5.2.2. Drug Products

Chapter 5. Market Segmentation 2: By Type of Industry Estimates & Trend Analysis

5.1. By Type of Industry & Market Share, 2024 & 2034

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Type of Industry:

5.2.1. Therapeutics and Vaccine Developers

5.2.2. CDMO Organizations

5.2.3. Custom Synthesis/cGMP Service Providers

Chapter 6. Market Segmentation 3: By Therapeutic Area Estimates & Trend Analysis

6.1. By Therapeutic Area & Market Share, 2024 & 2034

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Applications:

6.2.1. Infectious Disease

6.2.2. Oncological Disorders

6.2.3. Others 

Chapter 7. Market Segmentation 4: By Scale of Operation Estimates & Trend Analysis

7.1. By Scale of Operation & Market Share, 2024 & 2034

7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Scale of Operation:

7.2.1. Research / Preclinical

7.2.2. Clinical

7.2.3. Commercial

Chapter 8. Market Segmentation 4: By Application Estimates & Trend Analysis

8.1. By Application & Market Share, 2024 & 2034

8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Application:

8.2.1. mRNA-based Vaccines

8.2.2. mRNA-based Therapeutics

 

Chapter 9. mRNA Synthesis and Manufacturing Services Market Segmentation 5: Regional Estimates & Trend Analysis

9.1. North America

9.1.1. North America mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Products, 2021-2034

9.1.2. North America mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Applications, 2021-2034

9.1.3. North America mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts by Scale of Operation, 2021-2034

9.1.4. North America mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2021-2034

9.1.5. North America mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Type of Industry, 2021-2034

9.1.6. North America mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts by country, 2021-2034

 

9.2. Europe

9.2.1. EuropemRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Products, 2021-2034

9.2.2. Europe mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Applications, 2021-2034

9.2.3. Europe mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts by Scale of Operation, 2021-2034

9.2.4. Europe mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2021-2034

9.2.5. Europe mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Type of Industry, 2021-2034

9.2.6. Europe mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts by country, 2021-2034

9.3. Asia Pacific

9.3.1. Asia Pacific mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Products, 2021-2034

9.3.2. Asia Pacific mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Applications, 2021-2034

9.3.3. Asia Pacific mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts by Scale of Operation, 2021-2034

9.3.4. Asia Pacific mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2021-2034

9.3.5. Asia Pacific mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Type of Industry, 2021-2034

9.3.6. Asia Pacific mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts by country, 2021-2034

9.4. Latin America

9.4.1. Latin America mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Products, 2021-2034

9.4.2. Latin America mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Applications, 2021-2034

9.4.3. Latin America mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts by Scale of Operation, 2021-2034

9.4.4. Latin America mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2021-2034

9.4.5. Latin America mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Type of Industry, 2021-2034

9.4.6. Latin America mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts by country, 2021-2034

9.5. Middle East & Africa

9.5.1. Middle East & Africa mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Products, 2021-2034

9.5.2. Middle East & Africa mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Applications, 2021-2034

9.5.3. Middle East & Africa mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts by Scale of Operation, 2021-2034

9.5.4. Middle East & Africa mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2021-2034

9.5.5. Middle East & Africa mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Type of Industry, 2021-2034

9.5.6. Middle East & Africa mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts by country, 2021-2034

Chapter 10. Competitive Landscape

10.1. Major Mergers and Acquisitions/Strategic Alliances

10.2. Company Profiles

10.2.1. Eurogentec

10.2.2. Aldevron

10.2.3. eTheRNA (Etherna Immunotherapies)

10.2.4. bioSYNTHESIS

10.2.5. TriLink BioTechnologies

10.2.6. Biomay

102.7. Jena Biosciences

10.2.8. APExBIO

10.2.9. CELLSCRIPT

10.2.10. Thermo Fisher Scientific

10.2.11. New England Biolabs

10.2.12. Celonic AG

10.2.13. Corden Pharma GmbH

10.2.14. Lonza Group AG

10.2.15. Rentschler Biopharma

10.2.16. Laboratorios Farmacéuticos Rovi, S.A.

10.2.17. Samsung Biologics

10.2.18. CureVac

10.2.19. Moderna

10.2.20. BioNTech (Pfizer)

10.2.21. Translate Bio

10.2.22. Ethris (AstraZeneca)

10.2.23. Kernal Biologics

10.2.24. Silence Therapeutics

10.2.25. Tiba Biotechnology

10.2.26. In-Cell-Art

10.2.27. Anima Biotech

10.2.28. H3 Biomedicine Inc.

10.2.29. Arcturus Therapeutics

10.2.30. eFFECTOR Therapeutics, Inc.

10.2.31. Ionis Pharmaceuticals, Inc.

10.2.32. Stemirna Therapeutics Co., Ltd.

10.2.33. Skyhawk Therapeutics, Inc.

10.2.34. RNAimmune (Sirnaomics)

10.2.35. Ziphius Therapeutics NV

10.2.36. miRagen Therapeutics, Inc.

10.2.37. Strand Therapeutics Inc.

10.2.38. Other Prominent Players

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
3942
Security Code field cannot be blank!

Frequently Asked Questions

CureVac, Moderna, BioNTech (Pfizer), Translate Bio, Ethris (AstraZeneca), Silence Therapeutics, Tiba Biotechnology, In-Cell-Art, Anima Biotech, H3 Bio

mRNA Synthesis and Manufacturing Services Market is expected to grow at a 7.7% CAGR during the forecast period for 2025 to 2034

mRNA Synthesis and Manufacturing Services Market Size is valued at USD 958.5 Mn in 2024 and is predicted to reach USD 2,294.9 Mn by year 2034

By Type of Industry, Application, Scale of operations, Product and Therapeutic Area are the key segments of the Iprodione Market.

North American region is leading the mRNA Synthesis and Manufacturing Services Market.

Report License Selection

Determine the Appropriate License for your Report

Get Sample Report Enquiry Before Buying